Intravitreal Aflibercept for Submacular Hemorrhage

NCT03169660 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Exudative Age-related Macular Degeneration

Interventions

DRUG: Vascular endothelial growth factor trap-eye

Sponsor

Kim's Eye Hospital

Collaborators

[object Object]